Changchun Genescience Pharmaceutical Co., Ltd.
Clinical trials sponsored by Changchun Genescience Pharmaceutical Co., Ltd., explained in plain language.
-
New injection aims to starve breast cancer of hormones
Disease control OngoingThis study is testing a new injectable medication called leuprolide emulsion for premenopausal women with hormone-sensitive breast cancer. The goal is to see if it safely and effectively lowers estrogen levels to help control cancer growth when given alongside standard hormone th…
Phase: PHASE3 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test if new drug copy works the same as the original
Knowledge-focused OngoingThis study aims to see if a new version of the drug cabergoline works the same way in the body as an existing version. It will involve 72 healthy Chinese adults who will take both versions, once on an empty stomach and once after a meal. The main goal is to check if the two drug …
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC